Noriomi Matsumura

Researcher Name Resolver ID ORCID

Publication Activity (10 Years)

Years Active: 2014-2024
Publications (10 Years): 58

Top Venues

British journal of cancer

Healthcare (Basel, Switzerland)

International journal of clinical oncology

Cancer science

近畿大学医学部

This page only lists publications with an associated author ORCID identifier.

Affiliation History

近畿大学医学部 Apr 01 2017

Japan

教授 :: 産科婦人科

Publications

Shiro Takamatsu, Kosuke Murakami, Noriomi Matsumura
Homologous Recombination Deficiency Unrelated to Platinum and PARP Inhibitor Response in Cell Line Libraries. Scientific data 11 (1) (2024)
Shiro Takamatsu, Kosuke Murakami, Noriomi Matsumura
Homologous Recombination Deficiency Unrelated to Platinum and PARP Inhibitor Response in Cell Line Libraries. Scientific data 11 (1) (2024)
Hidekatsu Nakai, Noriomi Matsumura
Selection of maintenance therapy during first-line treatment of advanced ovarian cancer based on pharmacologic characteristics. Expert opinion on pharmacotherapy 24 (18) (2024)
Hidekatsu Nakai, Takahiro Higashi, Tamaki Kakuwa, Noriomi Matsumura
Trends in gynecologic cancer in Japan: incidence from 1980 to 2019 and mortality from 1981 to 2021. International journal of clinical oncology (2024)
Hidekatsu Nakai, Takahiro Higashi, Tamaki Kakuwa, Noriomi Matsumura
Trends in gynecologic cancer in Japan: incidence from 1980 to 2019 and mortality from 1981 to 2021. International journal of clinical oncology 29 (4) (2024)
Hidekatsu Nakai, Noriomi Matsumura
Selection of maintenance therapy during first-line treatment of advanced ovarian cancer based on pharmacologic characteristics. Expert opinion on pharmacotherapy 24 (18) (2024)
Hidekatsu Nakai, Takahiro Higashi, Tamaki Kakuwa, Noriomi Matsumura
Trends in gynecologic cancer in Japan: incidence from 1980 to 2019 and mortality from 1981 to 2021. International journal of clinical oncology 29 (4) (2024)
Shiro Takamatsu, R Tyler Hillman, Kosuke Yoshihara, Tsukasa Baba, Muneaki Shimada, Hiroshi Yoshida, Hiroaki Kajiyama, Katsutoshi Oda, Masaki Mandai, Aikou Okamoto, Takayuki Enomoto, Noriomi Matsumura
Molecular classification of ovarian high-grade serous/endometrioid carcinomas through multi-omics analysis: JGOG3025-TR2 study. British journal of cancer (2024)
Shiro Takamatsu, Kosuke Murakami, Noriomi Matsumura
Homologous Recombination Deficiency Unrelated to Platinum and PARP Inhibitor Response in Cell Line Libraries. Scientific data 11 (1) (2024)
Yoko Furutake, Ken Yamaguchi, Koji Yamanoi, Sachiko Kitamura, Shiro Takamatsu, Mana Taki, Masayo Ukita, Yuko Hosoe, Ryusuke Murakami, Kaoru Abiko, Akihito Horie, Junzo Hamanishi, Tsukasa Baba, Noriomi Matsumura, Masaki Mandai
YAP1 suppression by ZDHHC7 is associated with ferroptosis resistance and poor prognosis in ovarian clear cell carcinoma. Molecular cancer therapeutics (2024)
Risa Fujishima, Kaoru Kawasaki, Kaori Moriuchi, Reona Shiro, Yoshie Yo, Noriomi Matsumura
Conservative Management for Retained Products of Conception in Late Pregnancy. Healthcare (Basel, Switzerland) 11 (2) (2023)
Noriomi Matsumura, Reona Shiro, Ikuo Tsunoda
Critical evaluation on roles of macrophagic myofasciitis and aluminum adjuvants in HPV vaccine-induced adverse events. Cancer science (2023)
Noriomi Matsumura, Reona Shiro, Ikuo Tsunoda
Critical evaluation on roles of macrophagic myofasciitis and aluminum adjuvants in HPV vaccine-induced adverse events. Cancer science (2023)
Yoko Kashima, Kosuke Murakami, Chiho Miyagawa, Hisamitsu Takaya, Yasushi Kotani, Hidekatsu Nakai, Noriomi Matsumura
Treatment for Locally Resectable Stage IIIC1 Cervical Cancer: A Retrospective, Single-Institution Study. Healthcare (Basel, Switzerland) 11 (5) (2023)
Shiro Takamatsu, Kosuke Yoshihara, Tsukasa Baba, Muneaki Shimada, Hiroshi Yoshida, Hiroaki Kajiyama, Katsutoshi Oda, Masaki Mandai, Aikou Okamoto, Takayuki Enomoto, Noriomi Matsumura
Prognostic relevance of HRDness gene expression signature in ovarian high-grade serous carcinoma; JGOG3025-TR2 study. British journal of cancer (2023)
Toshihiro Shinohara, Kosuke Murakami, Noriomi Matsumura
Diagnosis Assistance in Colposcopy by Segmenting Acetowhite Epithelium Using U-Net with Images before and after Acetic Acid Solution Application. Diagnostics (Basel, Switzerland) 13 (9) (2023)
Shiro Takamatsu, Kosuke Yoshihara, Tsukasa Baba, Muneaki Shimada, Hiroshi Yoshida, Hiroaki Kajiyama, Katsutoshi Oda, Masaki Mandai, Aikou Okamoto, Takayuki Enomoto, Noriomi Matsumura
Prognostic relevance of HRDness gene expression signature in ovarian high-grade serous carcinoma; JGOG3025-TR2 study. British journal of cancer 128 (6) (2023)
Risa Fujishima, Kaoru Kawasaki, Kaori Moriuchi, Reona Shiro, Yoshie Yo, Noriomi Matsumura
Conservative Management for Retained Products of Conception in Late Pregnancy. Healthcare (Basel, Switzerland) 11 (2) (2023)
Mamiko Onuki, Fumiaki Takahashi, Takashi Iwata, Hiroshi Nakazawa, Hideaki Yahata, Hiroyuki Kanao, Koji Horie, Katsuyuki Konnai, Ai Nio, Kazuhiro Takehara, Shoji Kamiura, Naotake Tsuda, Yuji Takei, Shogo Shigeta, Noriomi Matsumura, Hiroyuki Yoshida, Takeshi Motohara, Hiroyuki Yamazaki, Keiichiro Nakamura, Junzo Hamanishi, Nobutaka Tasaka, Mitsuya Ishikawa, Yasuyuki Hirashima, Wataru Kudaka, Mayuyo Mori-Uchino, Iwao Kukimoto, Takuma Fujii, Yoh Watanabe, Kiichiro Noda, Hiroyuki Yoshikawa, Nobuo Yaegashi, Koji Matsumoto, null null
Human papillomavirus vaccine impact on invasive cervical cancer in Japan: Preliminary results from cancer statistics and the MINT study. Cancer science (2023)
Hidekatsu Nakai, Noriomi Matsumura
Selection of maintenance therapy during first-line treatment of advanced ovarian cancer based on pharmacologic characteristics. Expert opinion on pharmacotherapy (2023)
Hidekatsu Nakai, Noriomi Matsumura
Comment on 'Population-adjusted indirect treatment comparison of maintenance PARP inhibitor with or without bevacizumab versus bevacizumab alone in women with newly diagnosed advanced ovarian cancer'. ( Ther Adv Med Oncol . 2021 Sep 30;13:17588359211049639). Therapeutic advances in medical oncology 15 (2023)
Toshihiro Shinohara, Kosuke Murakami, Noriomi Matsumura
Diagnosis Assistance in Colposcopy by Segmenting Acetowhite Epithelium Using U-Net with Images before and after Acetic Acid Solution Application. Diagnostics (Basel, Switzerland) 13 (9) (2023)
Noriomi Matsumura, Reona Shiro, Ikuo Tsunoda
Critical evaluation on roles of macrophagic myofasciitis and aluminum adjuvants in HPV vaccine-induced adverse events. Cancer science (2023)
Chiho Miyagawa, Hidekatsu Nakai, Tomoyuki Otani, Ryusuke Murakami, Shiki Takamura, Hisamitsu Takaya, Kosuke Murakami, Masaki Mandai, Noriomi Matsumura
Histopathological subtyping of high-grade serous ovarian cancer using whole slide imaging. Journal of gynecologic oncology (2023)
Ayako Suzuki, Aki Kido, Mitsuru Matsuki, Yasushi Kotani, Kosuke Murakami, Yukio Yamanishi, Isao Numoto, Hidekatsu Nakai, Tomoyuki Otani, Ikuo Konishi, Masaki Mandai, Noriomi Matsumura
Development of an Algorithm to Differentiate Uterine Sarcoma from Fibroids Using MRI and LDH Levels. Diagnostics (Basel, Switzerland) 13 (8) (2023)
Ayako Suzuki, Aki Kido, Mitsuru Matsuki, Yasushi Kotani, Kosuke Murakami, Yukio Yamanishi, Isao Numoto, Hidekatsu Nakai, Tomoyuki Otani, Ikuo Konishi, Masaki Mandai, Noriomi Matsumura
Development of an Algorithm to Differentiate Uterine Sarcoma from Fibroids Using MRI and LDH Levels. Diagnostics (Basel, Switzerland) 13 (8) (2023)
Shiro Takamatsu, Kosuke Yoshihara, Tsukasa Baba, Muneaki Shimada, Hiroshi Yoshida, Hiroaki Kajiyama, Katsutoshi Oda, Masaki Mandai, Aikou Okamoto, Takayuki Enomoto, Noriomi Matsumura
Prognostic relevance of HRDness gene expression signature in ovarian high-grade serous carcinoma; JGOG3025-TR2 study. British journal of cancer 128 (6) (2023)
Yoshie Yo, Kaoru Kawasaki, Kaori Moriuchi, Reona Shiro, Masao Shimaoka, Noriomi Matsumura
The Effect of Sexual Intercourse during Pregnancy on Preterm Birth: Prospective Single-Center Cohort Study in Japan. Healthcare (Basel, Switzerland) 11 (11) (2023)
Shiro Takamatsu, Kosuke Yoshihara, Tsukasa Baba, Muneaki Shimada, Hiroshi Yoshida, Hiroaki Kajiyama, Katsutoshi Oda, Masaki Mandai, Aikou Okamoto, Takayuki Enomoto, Noriomi Matsumura
Prognostic relevance of HRDness gene expression signature in ovarian high-grade serous carcinoma; JGOG3025-TR2 study. British journal of cancer 128 (6) (2023)
Yoko Kashima, Kosuke Murakami, Chiho Miyagawa, Hisamitsu Takaya, Yasushi Kotani, Hidekatsu Nakai, Noriomi Matsumura
Treatment for Locally Resectable Stage IIIC1 Cervical Cancer: A Retrospective, Single-Institution Study. Healthcare (Basel, Switzerland) 11 (5) (2023)
Shiro Takamatsu, Kosuke Yoshihara, Tsukasa Baba, Muneaki Shimada, Hiroshi Yoshida, Hiroaki Kajiyama, Katsutoshi Oda, Masaki Mandai, Aikou Okamoto, Takayuki Enomoto, Noriomi Matsumura
Prognostic relevance of HRDness gene expression signature in ovarian high-grade serous carcinoma; JGOG3025-TR2 study. British journal of cancer 128 (6) (2023)
Shiro Takamatsu, Kosuke Yoshihara, Tsukasa Baba, Muneaki Shimada, Hiroshi Yoshida, Hiroaki Kajiyama, Katsutoshi Oda, Masaki Mandai, Aikou Okamoto, Takayuki Enomoto, Noriomi Matsumura
Prognostic relevance of HRDness gene expression signature in ovarian high-grade serous carcinoma; JGOG3025-TR2 study. British journal of cancer 128 (6) (2023)
Hidekatsu Nakai, Noriomi Matsumura
Comment on 'Population-adjusted indirect treatment comparison of maintenance PARP inhibitor with or without bevacizumab versus bevacizumab alone in women with newly diagnosed advanced ovarian cancer'. ( Ther Adv Med Oncol . 2021 Sep 30;13:17588359211049639). Therapeutic advances in medical oncology 15 (2023)
Reona Shiro, Yasushi Kotani, Mamiko Ohta, Hanako Sato, Yoko Kashima, Kosuke Murakami, Kaoru Kawasaki, Hidekatsu Nakai, Noriomi Matsumura
Diagnostic Utility of Hysteroscopic Biopsy in Cases of Suspected Lobular Endocervical Glandular Hyperplasia and Comparison with Cervical Conization. Healthcare (Basel, Switzerland) 11 (11) (2023)
Risa Fujishima, Kaoru Kawasaki, Kaori Moriuchi, Reona Shiro, Yoshie Yo, Noriomi Matsumura
Conservative Management for Retained Products of Conception in Late Pregnancy. Healthcare (Basel, Switzerland) 11 (2) (2023)
Hidekatsu Nakai, Noriomi Matsumura
Comment on 'Population-adjusted indirect treatment comparison of maintenance PARP inhibitor with or without bevacizumab versus bevacizumab alone in women with newly diagnosed advanced ovarian cancer'. ( Ther Adv Med Oncol . 2021 Sep 30;13:17588359211049639). Therapeutic advances in medical oncology 15 (2023)
Hidekatsu Nakai, Noriomi Matsumura
Selection of maintenance therapy during first-line treatment of advanced ovarian cancer based on pharmacologic characteristics. Expert opinion on pharmacotherapy (2023)
Kosuke Yoshihara, Tsukasa Baba, Hideaki Tokunaga, Koji Nishino, Masayuki Sekine, Shiro Takamatsu, Noriomi Matsumura, Hiroshi Yoshida, Hiroaki Kajiyama, Muneaki Shimada, Tatsuo Kagimura, Katsutoshi Oda, Yuko Sasajima, Nobuo Yaegashi, Aikou Okamoto, Toru Sugiyama, Takayuki Enomoto
Homologous Recombination Inquiry Through Ovarian Malignancy Investigations: JGOG3025 study. Cancer science (2023)
Shiro Takamatsu, Junzo Hamanishi, J B Brown, Ken Yamaguchi, Koji Yamanoi, Kosuke Murakami, Osamu Gotoh, Seiichi Mori, Masaki Mandai, Noriomi Matsumura
Mutation burden-orthogonal tumor genomic subtypes delineate responses to immune checkpoint therapy. Journal for immunotherapy of cancer 10 (7) (2022)
Kaoru Abiko, Junzo Hamanishi, Noriomi Matsumura, Masaki Mandai
Dynamic host immunity and PD-L1/PD-1 blockade efficacy: developments after "IFN-γ from lymphocytes induces PD-L1 expression and promotes progression of ovarian cancer". British journal of cancer (2022)
Kaori Moriuchi, Kaoru Kawasaki, Maako Hayashi, Akihiko Ueda, Yukio Yamanishi, Haruta Mogami, Kohei Fujita, Reona Shiro, Yoshie Yo, Masaki Mandai, Noriomi Matsumura
Plasma Antithrombin Activity during Long-Term Magnesium Sulfate Administration for Preeclampsia without Severe Hypertension. Healthcare (Basel, Switzerland) 10 (8) (2022)
Tomoyuki Otani, Noriomi Matsumura, Akihiko Ito
HER2-amplified endometrial carcinoma and AFP-producing endometrial carcinoma. Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc 35 (12) (2022)
Hidekatsu Nakai, Noriomi Matsumura
Individualization in the first-line treatment of advanced ovarian cancer based on the mechanism of action of molecularly targeted drugs. International journal of clinical oncology 27 (6) (2022)
Shiro Takamatsu, J B Brown, Ken Yamaguchi, Junzo Hamanishi, Koji Yamanoi, Hisamitsu Takaya, Tomoko Kaneyasu, Seiichi Mori, Masaki Mandai, Noriomi Matsumura
Utility of Homologous Recombination Deficiency Biomarkers Across Cancer Types. JCO precision oncology 6 (2022)
Noriomi Matsumura, Ikuo Tsunoda
Scientific evaluation of alleged findings in HPV vaccines: Molecular mimicry and mouse models of vaccine-induced disease. Cancer science 113 (10) (2022)
Hiroshi Asano, Katsutoshi Oda, Kosuke Yoshihara, Yuichiro Abe, Noriomi Matsumura, Muneaki Shimada, Hidemichi Watari, Takayuki Enomoto
Phase II study of niraparib in recurrent or persistent rare fraction of gynecologic malignancies with homologous recombination deficiency (JGOG2052). Journal of gynecologic oncology 33 (4) (2022)
Ikuo Konishi, Kaoru Abiko, Takuma Hayashi, Koji Yamanoi, Ryusuke Murakami, Ken Yamaguchi, Junzo Hamanishi, Tsukasa Baba, Noriomi Matsumura, Masaki Mandai, null null
Peritoneal dissemination of high-grade serous ovarian cancer: pivotal roles of chromosomal instability and epigenetic dynamics. Journal of gynecologic oncology 33 (5) (2022)
Hidekatsu Nakai, Noriomi Matsumura
The roles and limitations of bevacizumab in the treatment of ovarian cancer. International journal of clinical oncology 27 (7) (2022)
Taito Miyamoto, Ryusuke Murakami, Junzo Hamanishi, Kenji Tanigaki, Yuko Hosoe, Nathan Mise, Shiro Takamatsu, Yuka Mise, Masayo Ukita, Mana Taki, Koji Yamanoi, Naoki Horikawa, Kaoru Abiko, Ken Yamaguchi, Tsukasa Baba, Noriomi Matsumura, Masaki Mandai
B7-H3 suppresses anti-tumor immunity via the CCL2-CCR2-M2 macrophage axis and contributes to ovarian cancer progression. Cancer immunology research (2021)
Shiro Takamatsu, J B Brown, Ken Yamaguchi, Junzo Hamanishi, Koji Yamanoi, Hisamitsu Takaya, Tomoko Kaneyasu, Seiichi Mori, Masaki Mandai, Noriomi Matsumura
Utility of Homologous Recombination Deficiency Biomarkers Across Cancer Types. JCO precision oncology 5 (2021)
Mitsuhiro Nakamura, Ryusuke Murakami, Kaoru Abiko, Taito Miyamoto, Yoshimi Kitawaki, Ken Yamaguchi, Akihito Horie, Junzo Hamanishi, Eiji Kondoh, Tsukasa Baba, Aki Kido, Sachiko Minamiguchi, Noriomi Matsumura, Masaki Mandai
Corrigendum to "Low-Grade Endometrial Stromal Sarcoma with a Nodule-in-Nodule Appearance in Preoperative Magnetic Resonance Images". Case reports in obstetrics and gynecology 2021 (2021)
Mana Taki, Kaoru Abiko, Masayo Ukita, Ryusuke Murakami, Koji Yamanoi, Ken Yamaguchi, Junzo Hamanishi, Tsukasa Baba, Noriomi Matsumura, Masaki Mandai
Tumor Immune Microenvironment during Epithelial-Mesenchymal Transition. Clinical cancer research : an official journal of the American Association for Cancer Research 27 (17) (2021)
Kosuke Murakami, Akiko Kanto, Kazuko Sakai, Chiho Miyagawa, Hisamitsu Takaya, Hidekatsu Nakai, Yasushi Kotani, Kazuto Nishio, Noriomi Matsumura
Frequent PIK3CA mutations in eutopic endometrium of patients with ovarian clear cell carcinoma. Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc 34 (11) (2021)
Hideki Tokunaga, Mikio Mikami, Satoru Nagase, Yoichi Kobayashi, Tsutomu Tabata, Masanori Kaneuchi, Toyomi Satoh, Yasuyuki Hirashima, Noriomi Matsumura, Yoshihito Yokoyama, Kei Kawana, Satoru Kyo, Daisuke Aoki, Hidetaka Katabuchi
The 2020 Japan Society of Gynecologic Oncology guidelines for the treatment of ovarian cancer, fallopian tube cancer, and primary peritoneal cancer. Journal of gynecologic oncology 32 (2) (2021)
Hisamitsu Takaya, Hidekatsu Nakai, Shiro Takamatsu, Masaki Mandai, Noriomi Matsumura
Homologous recombination deficiency status-based classification of high-grade serous ovarian carcinoma. Scientific reports 10 (1) (2020)
Kosuke Murakami, Yasushi Kotani, Reona Shiro, Hisamitsu Takaya, Hidekatsu Nakai, Noriomi Matsumura
Endometriosis-associated ovarian cancer occurs early during follow-up of endometrial cysts. International journal of clinical oncology 25 (1) (2019)
Sachiko Kitamura, Kaoru Abiko, Noriomi Matsumura, Hidekatsu Nakai, Yumiko Akimoto, Hirotoshi Tanimoto, Ikuo Konishi
Adult granulosa cell tumors of the ovary: a retrospective study of 30 cases with respect to the expression of steroid synthesis enzymes. Journal of gynecologic oncology 28 (4) (2018)
Yuki Fukutani, Yoshitsugu Chigusa, Eiji Kondoh, Kaoru Kawasaki, Shingo Io, Noriomi Matsumura
Pneumocystis Pneumonia in Non-HIV Pregnant Women Receiving Chemotherapy for Malignant Lymphoma: Two Case Reports. Case reports in obstetrics and gynecology 2017 (2017)
Masafumi Koshiyama, Noriomi Matsumura, Ikuo Konishi
Recent concepts of ovarian carcinogenesis: type I and type II. BioMed research international 2014 (2014)

Noriomi Matsumura.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Noriomi Matsumura